Dialog Box

Access to new medicines and novel technologies in ovarian cancer.

Have your say! Access to new medicines and novel technologies in ovarian cancer.

Ovarian Cancer Australia welcomes the Parliamentary Inquiry into new drugs and novel technologies. The Inquiry by the House of Representatives Standing Committee on Health, Aged Care and Sport will include a focus on access to treatment for rare diseases and conditions where there is high and unmet need. 

The ovarian cancer community has a wealth of knowledge and real-life experiences that should be shared. Please consider having your say to ensure that the Inquiry’s outcomes are focussed on the needs of women with ovarian cancer. 

 There are two ways that you can have your say: 

1. Complete the  OCA survey below and your responses will be included in the Ovarian Cancer Australia Submission. Click on the following link to complete the survey OCA senate inquiry survey Please complete this by 7 October 2020. 

 2. You can complete your own submission all information on how you can do this is at the following link Senate inquiry website. The closing date is 13 October 2020. 

Thank you to everyone who decides to support Ovarian Cancer Australia’s efforts for improving access to new drugs and technology.  It will help eliminate the obstacles and pave the way for faster access to drugs in the future for people with ovarian cancer.  

Click here to take part in the survey.


24 September 2020
Category: News